These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23824562)

  • 21. Detection of conformational changes in immunoglobulin G using isothermal titration calorimetry with low-molecular-weight probes.
    Rispens T; Lakemond CM; Derksen NI; Aalberse RC
    Anal Biochem; 2008 Sep; 380(2):303-9. PubMed ID: 18577365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
    Singh SM; Bandi S; Jones DNM; Mallela KMG
    J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of antibody-polyol interactions by static light scattering: implications for physical stability of protein formulations.
    Abbas SA; Sharma VK; Patapoff TW; Kalonia DS
    Int J Pharm; 2013 May; 448(2):382-9. PubMed ID: 23583711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments.
    Welfle K; Misselwitz R; Hausdorf G; Höhne W; Welfle H
    Biochim Biophys Acta; 1999 Apr; 1431(1):120-31. PubMed ID: 10209285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of polyelectrolyte-driven Fab fragment separation.
    Capito F; Kolmar H; Edelmann B; Skudas R
    Biotechnol J; 2014 May; 9(5):698-701. PubMed ID: 24659538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
    Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
    Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients.
    Santana H; González Y; Campana PT; Noda J; Amarantes O; Itri R; Beldarraín A; Páez R
    Int J Pharm; 2013 Aug; 452(1-2):52-62. PubMed ID: 23624083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and stabilization of recombinant human protein pentraxin (rhPTX-2).
    Liu J; Blasie CA; Shi S; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Mar; 102(3):827-41. PubMed ID: 23160921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody.
    Menzen T; Friess W
    J Pharm Sci; 2014 Feb; 103(2):445-55. PubMed ID: 24382634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment.
    Zhang C; Samad M; Yu H; Chakroun N; Hilton D; Dalby PA
    Mol Pharm; 2018 Aug; 15(8):3079-3092. PubMed ID: 29897777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye.
    Tesar D; Luoma J; Wyatt EA; Shi C; Shatz W; Hass PE; Mathieu M; Yi L; Corn JE; Maass KF; Wang K; Dion MZ; Andersen N; Loyet KM; van Lookeren Campagne M; Rajagopal K; Dickmann L; Scheer JM; Kelley RF
    MAbs; 2017; 9(8):1297-1305. PubMed ID: 28854082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative binding of disulfide-bridged PEG-Fabs.
    Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
    Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment.
    Chakroun N; Hilton D; Ahmad SS; Platt GW; Dalby PA
    Mol Pharm; 2016 Feb; 13(2):307-19. PubMed ID: 26692229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities.
    Wang S; Zhang X; Wu G; Tian Z; Qian F
    Int J Pharm; 2017 Sep; 530(1-2):173-186. PubMed ID: 28755991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.